(Q48610567)

13 February 2018

title

The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia. (English)

1 reference

13 February 2018

1 reference

Marzella PL

1

1 reference

13 February 2018

Hill C

2

1 reference

13 February 2018

Keks N

3

1 reference

13 February 2018

Singh B

4

1 reference

13 February 2018

Copolov D

5

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

13 February 2018

published in

Biological Psychiatry

1 reference

13 February 2018

volume

42

1 reference

13 February 2018

issue

8

1 reference

13 February 2018

page(s)

648-654

1 reference

13 February 2018

Amphetamine psychosis: behavioral and biochemical aspects.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

No D2 receptor increase in PET study of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Selective cortical infarction reduces [3H]sulpiride binding in rat caudate-putamen: autoradiographic evidence for presynaptic D2 receptors on corticostriate terminals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Dopamine receptor subtype imbalance in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Multiple receptors for dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Elevation of brain neuroleptic/dopamine receptors in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Dopamine receptors and schizophrenia: drug effect or illness?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Increased brain dopamine and dopamine receptors in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Increased dopamine-receptor sensitivity in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

DOPAMINE RECEPTORS AND SCHIZOPHRENIA: DRUG EFFECT OR ILLNESS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Increased [3H] raclopride binding sites in postmortem brains from schizophrenic violent suicide victims.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Antipsychotic drug doses and neuroleptic/dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Dopamine receptor parameters detected by [3H]spiperone depend on tissue concentration: analysis and examples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Dopamine D4 receptors elevated in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Molecular biology of dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

[3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900471-4

10.1016/S0006-3223(96)00471-4

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

9325557

1 reference

13 February 2018